Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Norman Heyden"'
Autor:
Elizabeth Rosenberg, T. J. de Villiers, J. Foldes, Albert T. Leung, Norman Heyden, Felicia Cosman, Andrew Denker, Arthur C. Santora, N. Gilchrist, Michael R. McClung, J.P. McGinnis, Suvajit Samanta
Publikováno v:
Osteoporosis International. 27:377-386
Summary: In women with osteoporosis treated with alendronate for > 12 months and oral bisphosphonates for > 3 of the last 4 years, switching to MK-5442, a calcium receptor antagonist, stimulated endogenous parathyroid hormone (PTH) secretion and incr
Autor:
P. J. Meunier, Anthony L. Mulloy, Ronald Emkey, Antonio Lombardi, Norman H. Bell, Stuart R. Weiss, Robert W. Downs, Thomas Musliner, Susan L. Greenspan, Shailaja Suryawanshi, Norman Heyden, Sam S. Miller, Clark McKeever, Michael H. Davidson, A. J. Yates, Henry G. Bone, Robert R. Recker
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 85:720-726
The bisphosphonate alendronate and conjugated equine estrogens are both widely used for the treatment of postmenopausal osteoporosis. Acting by different mechanisms, these two agents decrease bone resorption and thereby increase or preserve bone mine
Autor:
Shailaja Suryawanshi, Stuart R. Weiss, Antonio Lombardi, A. John Yates, Henry G. Bone, Pierre J. Meunier, Sam S. Miller, Robert R. Recker, Norman Heyden, Norman H. Bell, Ronald Emkey, Susan L. Greenspan, Thomas Musliner, Robert W. Downs, Clark McKeever, Michael H. Davidson, Anthony L. Mulloy
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 85:720-726
The bisphosphonate alendronate and conjugated equine estrogens are both widely used for the treatment of postmenopausal osteoporosis. Acting by different mechanisms, these two agents decrease bone resorption and thereby increase or preserve bone mine